Article Information
History
- January 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Wei Song1,2,4,#,
- Haixi Zhang3,#,
- Fan Yang2,
- Kiichi Nakahira5,6,
- Cheng Wang7,
- Keqian Shi3,* and
- Ruoyu Zhang7,*
- 1Faculty of Life science and Technology, Kunming University of Science and Technology, Kunming, 650500, Yunnan, P.R. China
- 2School of Medicine, Kunming University of Science and Technology, Kunming, 650500, Yunnan, P.R. China
- 3Department of Hematology, The First People’s Hospital of Yunnan Province, Kunming, 650032, Yunnan, P.R. China
- 4Department of Radiology, The First People’s Hospital of Yunnan Province, Kunming, 650032, Yunnan, P.R. China
- 5Department of Pharmacology, Nara Medical University, Kashihara, Nara, 634-8521, Japan
- 6Division of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, New York, 10065, USA
- 7Innovec Biotherapeutics, Inc. Beijing, 102206, P.R. China
- ↵*Corresponding authors., E-mail address: zry0510{at}gmail.com (R Zhang) and shikeqian1{at}outlook.com (K Shi)
↵# These authors contributed equally to this work.
Posted January 18, 2022.
Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression
